Health Stocks Surge, Shrugging Off Uncertainty in Washington
- Sharp rally closes gap after sector trailed the market’s gains
- Investors flood into biotech ETF, look to snap up bargains
Can the Senate Health Bill Unite Divided Republicans?
This article is for subscribers only.
There’s plenty of uncertainty about health policy in Washington, but on Wall Street, investors have a clear hunger for health stocks.
After Republican Donald Trump’s presidential-election victory, the health-care sector trailed the pack as the wider market rallied. Heated campaign rhetoric from Trump and Democratic rival Hillary Clinton made investors wary that Washington would tamp down drug prices and take other steps to radically remake the health-care marketplace.